Compare StocksPAYX vs PFE

Paychex, Inc. (PAYX) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-19, PAYX is overvalued at $98, with a DCF intrinsic value of $89 and a margin of safety of -11%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, PAYX has the wider margin of safety.

PAYX
Paychex, Inc.
$98.24
VS
PFE
Pfizer Inc.
$25.21

Rewards

PAYX
  • Paychex, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 67.2% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Paychex, Inc. scores 94/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

PAYX
    PFE
    • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
    • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
    • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

    Key Valuation Metrics

    Learn more →
    PAYX
    PFE
    Valuation
    N/A
    Free Cash Flow
    $12.38B
    N/A
    FCF Yield
    8.61%
    21.69
    Trailing P/E
    19.24
    16.66
    Forward P/E
    8.91
    Quality & Moat
    15.41%
    ROIC
    10.19%
    41.29%
    ROE
    8.31%
    67.20%
    Gross Margin
    74.80%
    1.74
    PEG Ratio
    13.77
    Balance Sheet Safety
    0.81
    Net Debt / Equity
    0.57
    N/A
    Interest Coverage
    N/A
    2.01
    Net Debt / EBITDA
    2.03
    0.00%
    Dividend Yield
    6.61%
    PAYX: 3Ties: 2PFE: 5
    PAYXPFE

    Historical Fundamentals

    Learn more →
    PAYX

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    PFE

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    PAYX
    $-1.19
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $966.2M
    Δ Market Cap
    $-1.15B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    PFE
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-10.61B
    Δ Market Cap
    $-146.18B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    PAYX
    10.9% Overvalued
    Price is 10.9% above estimated fair value
    Current Price: $98.24
    Fair Value: $88.60
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    PFE
    12.3% Overvalued
    Price is 12.3% above estimated fair value
    Current Price: $25.21
    Fair Value: $22.46
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    PAYX

    Requires positive FCF to compute implied growth rate.

    PFE

    What growth rate is the market pricing in at $25?

    +5.2%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +4.5%

    The market implies +5.2% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    PAYX
    94/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Margin Stability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    PFE
    35/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    PAYX
    -2.93
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    PFE
    -2.53
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    PAYX
    Insiders 10.3%Institutions 85.2%Retail & Other 4.5%
    No. of Institutional Holders1,990
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    PFE
    Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
    No. of Institutional Holders3,744
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    PAYX
    0
    Buys (3M)
    2
    Buys (12M)
    Total value (12M): $197,258
    DOODY JOSEPH G
    Director
    $98,760
    @ $98.76 · 2026-02-04
    BONADIO THOMAS F
    Director
    $98,498
    @ $98.50 · 2026-02-04
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    PFE
    0
    Buys (3M)
    0
    Buys (12M)
    BLAYLOCK RONALD E
    Director
    $499,072
    @ $25.65 · 2025-02-13
    GOTTLIEB SCOTT
    Director
    $28,240
    @ $28.24 · 2024-10-30
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    PAYX
    1
    Sells (3M)
    5
    Sells (12M)
    Total value (12M): $16.66M
    ROALDSEN ELIZABETH
    Officer
    $41,310
    @ $90.00 · 2026-05-13
    SCHRADER ROBERT L.
    Chief Financial Officer
    $444,391
    @ $140.63 · 2025-07-16
    SIMMONS CHRISTOPHER C
    Officer and Treasurer
    $259,826
    @ $140.98 · 2025-07-16
    GIBSON JOHN B JR
    Chief Executive Officer
    $1.76M
    @ $141.92 · 2025-07-16
    MUCCI MARTIN
    Chairman of the Board
    $14.16M
    @ $145.17 · 2025-07-10
    VELLI JOSEPH M
    Director
    $544,762
    @ $149.25 · 2025-04-15
    GIOJA MICHAEL E
    Officer
    $4.89M
    @ $154.59 · 2025-04-03
    BOTTINI MARK ANTHONY
    Officer
    $6.65M
    @ $141.87 · 2024-10-16
    SCHRADER ROBERT L.
    Chief Financial Officer
    $1.85M
    @ $142.35 · 2024-10-15
    GIOJA MICHAEL E
    Officer
    $3.67M
    @ $139.03 · 2024-10-09
    GIOJA MICHAEL E
    Officer
    $2.05M
    @ $139.18 · 2024-10-04
    DOODY JOSEPH G
    Director
    $1.13M
    @ $130.69 · 2024-08-26
    SIMMONS CHRISTOPHER C
    Officer and Treasurer
    $293,797
    @ $125.34 · 2024-08-16
    FLASCHEN DAVID J S
    Director
    $1.81M
    @ $125.21 · 2024-08-05
    FLASCHEN DAVID J S
    Director
    $1.21M
    @ $125.60 · 2024-07-26
    BOTTINI MARK ANTHONY
    Officer
    $1.11M
    @ $123.60 · 2024-07-24
    GIBSON JOHN B JR
    Chief Executive Officer
    $1.51M
    @ $119.53 · 2024-07-15
    MUCCI MARTIN
    Chairman of the Board
    $21.93M
    @ $117.04 · 2024-07-02
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    PFE
    1
    Sells (3M)
    1
    Sells (12M)
    Total value (12M): $51,400
    DAMICO JENNIFER B.
    Officer
    $51,400
    @ $25.70 · 2026-06-09
    DAMICO JENNIFER B.
    Officer
    $64,825
    @ $25.93 · 2025-03-04
    DAMICO JENNIFER B.
    Officer
    $147,714
    @ $28.66 · 2024-08-13
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    PAYX
    FearGreed
    😨Fear(36/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    PFE
    FearGreed
    😐Neutral(49/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    PAYX
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (36)
    PFE
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
    View PAYX Full AnalysisView PFE Full Analysis

    Frequently Asked Questions: PAYX vs PFE

    Is Paychex, Inc. or Pfizer Inc. more undervalued in 2026?

    Based on our discounted cash flow model, PAYX trades at a -10.9% margin of safety (intrinsic value $89 vs. price $98), compared to PFE's -12.3% margin of safety (intrinsic $22 vs. $25).

    Which stock has a wider economic moat, Paychex, Inc. or Pfizer Inc.?

    PAYX scores 94/100 (Wide moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Pfizer Inc. in financial distress?

    PFE's Altman Z-Score of 2.1 places it in the Grey zone, signaling elevated bankruptcy risk. PAYX scores 3.1 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, Paychex, Inc. or Pfizer Inc.?

    PAYX earns 15.4% ROIC versus PFE's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, Paychex, Inc.'s or Pfizer Inc.'s?

    PAYX's dividend earns a safety score of 34/100 (Unsafe), compared to PFE's 24/100 (Unsafe). PAYX has raised its dividend for 3 consecutive years.

    PAYX vs PFE: Which Is the Better Buy in 2026? | SafetyMargin.io